TherapeuticsMD (TXMD) Cash from Investing Activities (2011 - 2022)
TherapeuticsMD (TXMD) posted Cash from Investing Activities of -$74000.0 for Q4 2022, down 1157.14% on a QoQ basis from $7000.0 in Q3 2022, and up 95.11% year-over-year from -$37926.9 in Q4 2021.
TherapeuticsMD (TXMD) Cash from Investing Activities (2011 - 2022) Analysis & Trends
TherapeuticsMD's Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$74000.0 for Q4 2022.
- Quarterly Cash from Investing Activities rose 95.11% year-over-year to -$74000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$355000.0 (up 84.03% YoY) and the FY2022 annual result came in at -$355000.0, up 84.03% from the prior year.
- Cash from Investing Activities was -$74000.0 for Q4 2022 at TherapeuticsMD, down from $7000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7000.0 in Q3 2022 and bottomed at -$20.7 million in Q4 2019.
- A 5-year average of -$2.5 million and a median of -$418500.0 in 2020 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2018 — Cash from Investing Activities tumbled 28077.04% — and 2022, when it jumped 103.85%.
- TherapeuticsMD's Cash from Investing Activities stood at -$671171.0 in 2018, then tumbled by 2986.19% to -$20.7 million in 2019, then soared by 97.62% to -$494000.0 in 2020, then plunged by 206.48% to -$1.5 million in 2021, then surged by 95.11% to -$74000.0 in 2022.
- Business Quant data shows TXMD's Cash from Investing Activities at -$74000.0 in Q4 2022, $7000.0 in Q3 2022, and -$76000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -74,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Jun 30, 2022 | -76,000.00 |
| Mar 31, 2022 | -212,000.00 |
| Mar 31, 2022 | -212,000.00 |
| Dec 31, 2021 | -1.51 Mn |
| Dec 31, 2021 | -1.51 Mn |
| Sep 30, 2021 | -182,000.00 |
| Sep 30, 2021 | -182,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Jun 30, 2021 | -89,000.00 |
| Mar 31, 2021 | -438,000.00 |
| Mar 31, 2021 | -438,000.00 |
| Dec 31, 2020 | -494,000.00 |
| Dec 31, 2020 | -494,000.00 |
| Sep 30, 2020 | -262,000.00 |
| Sep 30, 2020 | -262,000.00 |